Alternative approaches to IP regulation
From PHM Oz
(Difference between revisions)
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 6: | Line 6: | ||
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [[http://www.who.int/intellectualproperty/en/ Web link]] | Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [[http://www.who.int/intellectualproperty/en/ Web link]] | ||
| + | |||
| + | Brewster et al (2005) [[http://www.biodevelopments.org/innovation/ist3.pdf Innovation Strategy Today]] | ||
Return to [[Intellectual Property and Pharmaceuticals | IP Resources page]] | Return to [[Intellectual Property and Pharmaceuticals | IP Resources page]] | ||
Revision as of 12:00, 9 July 2007
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [web reference]
Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [web link]
Universities Allied for Essential Medicines [web link]. Statement of Principles [Principles]
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [Web link]
Brewster et al (2005) [Innovation Strategy Today]
Return to IP Resources page
